- Diagnosis, risk stratification, selection of therapy, interim/post-therapy evaluation by MRD/PET-CT-based investigations, and subsequent modification of the therapeutic procedure have transformed the overall outcome of hematological malignancies.
- Molecular investigations are a requirement at all stages: Diagnosis, risk stratification, interim/MRD evaluation, etc.
- Matched unrelated donor/Haplo Allo BMT has enhanced the possibility of Allo BMT in most of the patients as a curative option.
- This first joint venture ICH-ICP e-Monogram, highlighting the above points, is primarily meant for postgraduates.
Model 9789356967717
Availability In Stock
JAYPEE PUBLISHERS
ICP-ICH Monogram on Advances in Hemato-oncology;1st Edition 2024 by RK Jena & HP Pati
Rs. 1,030.00
Rs. 1,295.00
- Ex Tax: Rs. 1,030.00
.jpg)
20% Off.
